Walgreens September Sales Increase 8.0 Percent
October 03 2013 - 7:00AM
Business Wire
Walgreens (NYSE: WAG) (Nasdaq: WAG) had September sales of $5.92
billion, an increase of 8.0 percent from $5.48 billion for the same
month in fiscal 2013.
Total front-end sales increased 4.1 percent compared with the
same month in fiscal 2013, while comparable store front-end sales
increased 2.9 percent. Customer traffic in comparable stores
decreased 0.8 percent while basket size increased 3.7 percent.
Prescriptions filled at comparable stores increased by 9.6
percent in September and increased 6.7 percent on a calendar
day-shift adjusted basis. This year’s September had one additional
Monday and one fewer Saturday compared with September 2012. These
calendar shifts positively impacted prescriptions filled at
comparable stores by 2.9 percentage points.
Prescriptions filled at comparable stores also were positively
impacted by 0.8 percentage point due to more flu shots versus last
year and were negatively impacted by 0.2 percentage point due to
lower incidence of flu in this year’s September.
September pharmacy sales increased by 10.4 percent, while
comparable store pharmacy sales increased 10.2 percent and
increased by a calendar day-shift adjusted 7.3 percent. Calendar
day shifts positively impacted pharmacy sales in comparable stores
by 2.9 percentage points. Calendar day-shift adjusted comparable
store pharmacy sales were negatively impacted by 0.7 percentage
point due to generic drug introductions in the last 12 months, and
were positively impacted by 0.5 percentage point due to more flu
shots versus last year. Pharmacy sales accounted for 65.0 percent
of total sales for the month.
Flu shots administered at pharmacies and clinics season to date
were more than 1.9 million versus approximately 1.6 million last
year.
Sales in comparable stores increased by 7.4 percent in
September. Calendar day shifts positively impacted total comparable
sales by 1.9 percentage points, while generic drug introductions in
the last 12 months negatively impacted total comparable sales by
0.5 percentage point.
Calendar 2013 sales to date were $54.11 billion, an increase of
4.1 percent from $51.97 billion in 2012.
Walgreens opened 17 stores during September, including eight
relocations, and closed one.
On Sept. 30, Walgreens operated 8,590 locations in all 50
states, the District of Columbia, Puerto Rico, Guam and the U.S.
Virgin Islands. That includes 8,123 drugstores, 77 more than a year
ago, including five net stores acquired over the last 12 months.
The company also operates infusion and respiratory services
facilities, specialty pharmacies and mail service facilities. Its
Take Care Health Systems subsidiary manages more than 700 in-store
convenient care clinics and worksite health and wellness
centers.
September Comparable Sales and Prescriptions
Filled
Calendar
Cough,
Flu
Shift
Generics
Cold, Flu
Shot
Actual
Impact
Impact
Impact
Impact
Total Comp Sales 7.4 % 1.9 % -0.5 % 0.0 % 0.3 % Comp Front
End 2.9 % - - - - Comp Rx Sales 10.2 % 2.9 % - 0.7 % - 0.1 % 0.5 %
Comp Rx Scripts
9.6
%*
2.9 % - - 0.2 % 0.8 %
* Includes +2.3 percentage points from
patients filling more 90-day prescriptions
Please note: Sales numbers and the adjustments shown in the
table are preliminary, unaudited and subject to revision.
Comparable stores are defined as those drugstore locations open for
at least 12 consecutive months without closure for seven or more
consecutive days and without a major remodel or a natural disaster
in the past 12 months. Acquired operating locations and relocations
are not included as comparable stores for the first 12 months after
the acquisition or relocation.
Cautionary Note Regarding Forward-Looking Statements: Statements
in this release that are not historical are forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Words such as
"expect," “likely,” "outlook," “forecast,” "would," "could,"
"should," “can,” “will,” "project," "intend," "plan," "goal,”
“target,” “continue," "sustain," “synergy,” "on track," "believe,"
"seek," "estimate," "anticipate," "may," “possible,” "assume," and
variations of such words and similar expressions are intended to
identify such forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve
risks, assumptions and uncertainties, including, but not limited
to, those described in Item 1A (Risk Factors) of our most recent
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each
of which is incorporated herein by reference, and in other
documents that we file or furnish with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect,
actual results may vary materially from those indicated or
anticipated by such forward-looking statements. Accordingly, you
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date they are made. Except
to the extent required by law, Walgreens does not undertake, and
expressly disclaims, any duty or obligation to update publicly any
forward-looking statement after the date of this report, whether as
a result of new information, future events, changes in assumptions
or otherwise.
WalgreensMedia contact:Jim Graham, 847-315-2925orInvestor
contacts:Rick Hans, CFA, 847-315-2385Ashish Kohli, CFA,
847-315-3810http://news.walgreens.com@WalgreensNewsfacebook.com/Walgreens
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jun 2024 to Jul 2024
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jul 2023 to Jul 2024